Extracellular vesicles derived from astrocyte-treated with haFGF14-154 attenuate Alzheimer phenotype in AD miceAlzheimer's diseaseaFGFAEVsmiR-206-3pBDNFBackground: aFGF content in serum and cerebrospinal fluid is increased in Alzheimer's disease (AD) patients and attenuates the activation...
Intranasal administration of TAT-haFGF(14-154) attenuates disease progression in a mouse model of Alzheimer's disease. Neuroscience. 2012; 223:225-237.Lou G, Zhang Q, Xiao F, et al. Intranasal administration of TAT-haFGF14-154 attenuates disease progression in a mouse model of Alzheimer's...
Lou G,Zhang Q,Xiao F. Intranasal administration of TAT-haFGF(14-154) attenuates disease progression in a mouse model of Alzheimer's disease[J].Neuroscience,2012.225-237.Lou G, Zhang Q, Xiao F, et al. Intranasal administration of TAT-haFGFI.I attenuates disease progression in a mouse ...